diaxonhit (ALEHT:EN Paris)
Herve Duchesne de Lamotte MBA
Chief Financial Officer and Member of Management Board, Diaxonhit
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Hervé Duchesne De Lamotte, MBA, has been the Chief Financial Officer of ExonHit Therapeutics SA since November 4, 2009. Mr. Lamotte serves as the Chief Financial Officer and as a Vice President of IDM-Biotech. He has been a Vice President of Finance of Europe since August 2005 and General Manager of IDM S.A. since April 2006. Mr. de Lamotte worked at MIT, AT Kearney and Gestor Finance. Mr. de Lamotte co-founded IDM Pharma, Inc. since 1993. He has over 25 years of ...
65 Boulevard MassénaPhone: 33 1 53 94 77 00
Paris, Ile-de-France 75013
Fax: 33 1 53 94 77 07
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
MIT Sloan School of Management
Ecole Nationale Superieure De L'aeronautique Et De L'espace
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Paul De Potocki M.Sc.||Chief Executive Officer and President|
|602.4K NOK||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Coral Gables, FL | AT&TPosted: Dec 05
- Fort Worth, TX | Kindred HospitalsPosted: Dec 05